JAMA:克利夫兰诊所的研究显示,葡萄糖酸锌和维生素C对COVID-19无效

2021-02-14 Allan MedSci原创

克利夫兰诊所的研究人员发现,与标准治疗相比,葡萄糖酸锌或抗坏血酸(维生素C)或两者的组合不会显著降低COVID-19患者的症状严重程度或症状持续时间。

克利夫兰诊所的研究人员发现,与标准治疗相比,葡萄糖酸锌或抗坏血酸(维生素C)或两者的组合不会显著降低COVID-19患者的症状严重程度或症状持续时间。

自从COVID-19大流行开始以来,人们就对各种维生素在预防或治疗中的作用进行了广泛的猜测,但科学证据仍然有限。已知葡萄糖酸锌对于免疫功能很重要,它还在抗体和白细胞的产生中起作用,并且可以抵抗感染。维生素C,一种抗氧化剂,可以帮助保护细胞的损害,并具有增强免疫力的作用。

COVIDAtoZ临床试验招募了214例COVID-19患者。患者被随机分配接受葡萄糖酸锌(50 mg)/维生素C(8000 mg)或标准治疗。该研究因无效而中止,两组之间无显著差异。

克利夫兰诊所心脏血管与胸腔疾病研究所Milind Desai博士说:“当我们看到大流行在全球蔓延、感染和杀死数百万人时,医学界和消费者都争先恐后地尝试补充剂,他们认为这种补充剂可以预防感染或缓解COVID-19症状,所以这项研究就很有必要进行。虽然与标准护理相比,维生素C和锌在临床上被证明无效,但其他疗法的研究仍在继续”。

 

原始出处:

https://www.firstwordpharma.com/node/1800510?tsid=4

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1735876, encodeId=34d41e35876f8, content=<a href='/topic/show?id=f8022886617' target=_blank style='color:#2F92EE;'>#克利夫兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28866, encryptionId=f8022886617, topicName=克利夫兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=846834021388, createdName=s_pl2019, createdTime=Sun Sep 05 04:38:47 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925161, encodeId=223a9251613a, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed Feb 17 23:36:20 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311205, encodeId=e1141311205e8, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Tue Feb 16 12:38:47 CST 2021, time=2021-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924703, encodeId=662a924e030c, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>又灭了一个神药!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=健康达人, createdTime=Mon Feb 15 11:03:39 CST 2021, time=2021-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036454, encodeId=38ca103645441, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Mon Feb 15 00:38:47 CST 2021, time=2021-02-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1735876, encodeId=34d41e35876f8, content=<a href='/topic/show?id=f8022886617' target=_blank style='color:#2F92EE;'>#克利夫兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28866, encryptionId=f8022886617, topicName=克利夫兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=846834021388, createdName=s_pl2019, createdTime=Sun Sep 05 04:38:47 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925161, encodeId=223a9251613a, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed Feb 17 23:36:20 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311205, encodeId=e1141311205e8, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Tue Feb 16 12:38:47 CST 2021, time=2021-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924703, encodeId=662a924e030c, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>又灭了一个神药!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=健康达人, createdTime=Mon Feb 15 11:03:39 CST 2021, time=2021-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036454, encodeId=38ca103645441, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Mon Feb 15 00:38:47 CST 2021, time=2021-02-15, status=1, ipAttribution=)]
    2021-02-17 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1735876, encodeId=34d41e35876f8, content=<a href='/topic/show?id=f8022886617' target=_blank style='color:#2F92EE;'>#克利夫兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28866, encryptionId=f8022886617, topicName=克利夫兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=846834021388, createdName=s_pl2019, createdTime=Sun Sep 05 04:38:47 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925161, encodeId=223a9251613a, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed Feb 17 23:36:20 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311205, encodeId=e1141311205e8, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Tue Feb 16 12:38:47 CST 2021, time=2021-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924703, encodeId=662a924e030c, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>又灭了一个神药!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=健康达人, createdTime=Mon Feb 15 11:03:39 CST 2021, time=2021-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036454, encodeId=38ca103645441, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Mon Feb 15 00:38:47 CST 2021, time=2021-02-15, status=1, ipAttribution=)]
    2021-02-16 ycmayy
  4. [GetPortalCommentsPageByObjectIdResponse(id=1735876, encodeId=34d41e35876f8, content=<a href='/topic/show?id=f8022886617' target=_blank style='color:#2F92EE;'>#克利夫兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28866, encryptionId=f8022886617, topicName=克利夫兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=846834021388, createdName=s_pl2019, createdTime=Sun Sep 05 04:38:47 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925161, encodeId=223a9251613a, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed Feb 17 23:36:20 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311205, encodeId=e1141311205e8, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Tue Feb 16 12:38:47 CST 2021, time=2021-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924703, encodeId=662a924e030c, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>又灭了一个神药!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=健康达人, createdTime=Mon Feb 15 11:03:39 CST 2021, time=2021-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036454, encodeId=38ca103645441, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Mon Feb 15 00:38:47 CST 2021, time=2021-02-15, status=1, ipAttribution=)]
    2021-02-15 健康达人

    #新冠肺炎#又灭了一个神药!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1735876, encodeId=34d41e35876f8, content=<a href='/topic/show?id=f8022886617' target=_blank style='color:#2F92EE;'>#克利夫兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28866, encryptionId=f8022886617, topicName=克利夫兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=846834021388, createdName=s_pl2019, createdTime=Sun Sep 05 04:38:47 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925161, encodeId=223a9251613a, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed Feb 17 23:36:20 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311205, encodeId=e1141311205e8, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Tue Feb 16 12:38:47 CST 2021, time=2021-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924703, encodeId=662a924e030c, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>又灭了一个神药!, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=健康达人, createdTime=Mon Feb 15 11:03:39 CST 2021, time=2021-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036454, encodeId=38ca103645441, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Mon Feb 15 00:38:47 CST 2021, time=2021-02-15, status=1, ipAttribution=)]
    2021-02-15 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

相关资讯

维生素C真的可以用于新冠肺炎的预防和治疗吗?

网传维生素C可用于治疗新冠肺炎,这个说法有依据吗?我们来一探究竟。

NAT COMMUN:禁食加Vc,抗癌得力组合

饥饿模拟饮食可延缓肿瘤的进展,并使多种肿瘤对化疗产生敏感性,但至今为止,我们对其与非细胞毒性化合物联合使用的治疗潜力尚不甚了解。

水果越酸,维C含量就越高吗?

橙子、柠檬、猕猴桃…当你听到这些水果名时,会想到什么?酸酸的口感?富含维生素C?很多人都觉得口感中的酸味和维生素C的含量是成正比的,可事实上,这两者并没有直接的联系,不管是橙子还是柠檬,

JAMA:维生素C、皮质类固醇和维生素B1联合治疗对脓毒性休克患者器官衰竭的影响

在脓毒性休克患者中,联合应用维生素C、皮质类固醇和维生素B1对改善患者序贯器官衰竭评估得分没有显著影响

JAMA Net Open:维生素C真的有助于铁吸收吗?全新RCT试验告诉你答案

理论上,维生素C有助于吸收。然而,根据RCT的结果,维生素C可能没有报道和预期的那么有益。

Clin Epigenetics:口服维生素C可恢复血液恶性肿瘤患者的血浆维生素C的水平

血液恶性肿瘤患者往往缺乏维生素C,而维生素C对于TET诱导的5-甲基胞嘧啶(5mC)向5-羟甲基胞嘧啶(5hmC)的转化至关重要,这是活性DNA去甲基化的第一步。在此,我们研究口服维生素C补充剂是否可

拓展阅读

Front Med:COVID-19住院患者Casirivimab/imdevimab失败预测评分的开发和验证

Casirivimab和imdevimab是两种非竞争性、高亲和力的人IgG1抗COVID-19单克隆抗体,它们特异性结合COVID-19病毒刺突糖蛋白的受体结合域,从而阻断病毒进入宿主细胞。

Biomedicines:2型糖尿病住院患者COVID-19的长期预后

在T2D合并COVID-19患者中,随访观察到住院死亡率、卒中和心血管住院率增加。

Cureus:2型糖尿病状态、糖尿病并发症严重程度指数评分及其与COVID-19严重程度的关系

与非糖尿病患者相比,我们样本中的糖尿病患者发生COVID-19不良临床结果和住院死亡率的几率更高。

Lancet Infect Dis:口服VV116用于治疗轻中度COVID-19成人患者的有效性和安全性评价

目前,治疗COVID-19的医疗需求仍未得到满足,新型抗病毒药物-VV116可用于治疗轻中度COVID-19成人患者,能够显著缩短临床症状持续时间,与其他药物较少发生药物间相互作用,且安全性良好。

论文解读|Yihua Wang教授团队新研究揭示了揭示COVID-19对肺癌治疗和研究的深远影响

该文章揭示了此次大流行对肺癌治疗、临床试验、研究活动的影响。

JAMA Intern Med:COVID-19相关急性肾损伤与长期肾脏结果

与患有其他疾病相关AKI的患者相比,COVID-AKI住院幸存者的MAKE发生率、长期肾功能下降和死亡率均显著较低。